bioMérieux S.A.
OTC: BMXMF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Pierre Boulud
- Employees
- 14,147
- Headquarters
- Marcy l'Étoile, France
- IPO year
- 2017
- Market cap
- $9.2B
- Website
- https://www.biomerieux.com
Loading BMXMF…
Loading profile data…Frequently asked questions about BMXMF
What does bioMérieux S.A. (BMXMF) do?
Operating on a global scale, bioMérieux S.A. designs and produces in vitro diagnostic solutions specifically for detecting infectious diseases across the Americas, Europe, the Middle East, Africa, and Asia Pacific. The firm's offerings encompass diagnostic systems that analyze biological samples to identify infectious diseases, cardiovascular co...
Where does BMXMF trade?
bioMérieux S.A. (BMXMF) trades on the Other OTC.
What sector is BMXMF in?
bioMérieux S.A. (BMXMF) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of bioMérieux S.A.?
Pierre Boulud is the chief executive officer of bioMérieux S.A. (BMXMF).
Where is bioMérieux S.A. headquartered?
bioMérieux S.A. is headquartered in France.
Does BMXMF pay a dividend?
Yes — bioMérieux S.A. (BMXMF) paid a trailing twelve-month dividend of USD 1.13 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did BMXMF go public?
bioMérieux S.A. (BMXMF) completed its initial public offering in 2017.